XERS
Xeris Biopharma Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$5.46
-0.02 ▼ -0.36%
🌙 3월 13일 6:23 PM ET (한국 3/14 07:23)
$5.51
+0.05 ▲ +0.92%
| Index | RUT | P/E | - | EPS (ttm) | -0.01 | Insider Own | 7.16% | Shs Outstand | 0.17B | Perf Week | -6.02% |
| Market Cap | 0.94B | Forward P/E | 15.67 | EPS next Y | 183.86% | Insider Trans | -2.35% | Shs Float | 0.16B | Perf Month | -20.98% |
| Enterprise Value | 1.09B | PEG | - | EPS next Q | 0 | Inst Own | 58.77% | Short Float | 10.63% | Perf Quarter | -21.33% |
| Income | 0.00B | P/S | 3.23 | EPS this Y | 3726.44% | Inst Trans | 2.19% | Short Ratio | 8.14 | Perf Half Y | -28.91% |
| Sales | 0.29B | P/B | 66.29 | EPS next 5Y | - | ROA | 0.15% | Short Interest | 17.02M | Perf YTD | -30.45% |
| Book/sh | 0.08 | P/C | 8.48 | EPS past 3/5Y | - | ROE | - | 52W High | -45.83% ($10.08) | Perf Year | 19.74% |
| Cash/sh | 0.64 | P/FCF | 33.71 | Sales past 3/5Y | 38.33% 70.2% | ROIC | 0.21% | 52W Low | 43.5% ($3.81) | Perf 3Y | 351.24% |
| Dividend Est. | - | EV/EBITDA | 28.96 | EPS Y/Y TTM | 99.47% | Gross Margin | 81.7% | Volatility(W/M) | 4.51% 5.64% | Perf 5Y | 13.51% |
| Dividend TTM | - | EV/Sales | 3.73 | Sales Y/Y TTM | 43.72% | Oper. Margin | 8.53% | ATR (14) | 0.34 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.57 | EPS Q/Q | 279.3% | Profit Margin | 0.19% | RSI (14) | 27.78 | Recom | 1.43 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.19 | Sales Q/Q | 42.78% | SMA20 | -12.54% ($6.24) | Beta | 0.76 | Target Price | $11.14 |
| Payout | - | Debt/Eq | 18.85 | Earnings | 3000000 | SMA50 | -21.14% ($6.92) | Rel Volume | 0.7 | Prev Close | $5.48 |
| Employees | 435 | LT Debt/Eq | 18.4 | EPS/Sales Surpr. | 191.26% 4.39% | SMA200 | -20.49% ($6.87) | Avg Volume(3M) | 2.09M | Price | $5.46 |
| IPO | 2018/6/21 | Option/Short | Yes/Yes | Trades | 9711 | Volume | 1,469,049 | Change | -0.36% |
뉴스 로딩 중...